Literature DB >> 8817173

Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: low incidence of HCV infection.

G N Dalekos1, E Zervou, M H Merkouropoulos, E V Tsianos.   

Abstract

Intravenous heroin abusers comprise a high risk group for hepatitis B and C viruses (HBV and HCV) infection. Chronic alcoholics with liver disease (LD) also comprise a high risk group for HBV infection whereas the frequency of antibodies to HCV (anti-HCV) ranges from 27-42.6%. In this study, HBV and HCV infection markers were determined in alcoholic patients with (83 patients) or without LD (68 patients) in order to assess the prevalence of these markers (HBsAg, HBsAb, HBcAb and anti-HCV). The reason for the study was a lack of established data in this group of patients in Greece. The disease control groups consisted of 70 non-alcoholic hospitalized patients and 60 heroin addicts, whereas 1342 healthy blood donors were also investigated. Our results showed significantly increased prevalence of HBV infection markers in chronic alcoholic patients compared to healthy controls and non-alcoholic hospitalized patients. The findings were independent of the presence or absence of LD. In contrast to heroin addicts, where anti-HCV antibodies were observed in 90%, there was no difference in the prevalence of anti-HCV antibodies in chronic alcoholics (with or without LD), nonalcoholic hospitalized patients or healthy controls. In conclusion, we found that in this area of north-western Greece, chronic alcoholics, independent of the presence of LD, comprise a high risk group for HBV infection but very rarely have HCV infection. The latter finding may reflect technical or socio-economic differences regarding the lifestyle of our patients, and our population in general.

Entities:  

Mesh:

Year:  1996        PMID: 8817173     DOI: 10.1007/bf00144423

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  29 in total

1.  Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease.

Authors:  G V Papatheodoridis; I Delladetsima; M Koutelou; A Katsoulidou; A Hatzakis; N C Tassopoulos
Journal:  J Hepatol       Date:  1994-02       Impact factor: 25.083

2.  Hepatitis C virus and sexual transmission.

Authors:  G Hess; A Massing; S Rossol; H Schütt; R Clemens; K H Meyer zum Büschenfelde
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Alcoholic liver disease: morphological manifestations. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

Review 4.  Recent advances in the study of the epidemiology of hepatitis B.

Authors:  W Szmuness
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

5.  IgM antibodies to hepatitis C virus in chronic active hepatitis C in NW Greece. Solution or more questions?

Authors:  G N Dalekos; E Zervou; E V Tsianos
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083

6.  Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common.

Authors:  E V Tsianos; C N Masalas; M Merkouropoulos; G N Dalekos; R F Logan
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

7.  Comparison of serum hepatitis B surface antigen (HBsAg) and serum anticore with tissue HBsAg and hepatitis B core antigen (HBcAg).

Authors:  M Omata; A Afroudakis; C T Liew; M Ashcavai; R L Peters
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

8.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

9.  High frequency of antibodies to Hantaan virus and hepatitis C virus in chronic haemodialysis patients. Coincidence or cross-reaction?

Authors:  E V Tsianos; G N Dalekos; M Elisaf; E Zervou; K C Siamopoulos
Journal:  J Intern Med       Date:  1993-12       Impact factor: 8.989

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  9 in total

1.  Prevalence of hepatitis B and C markers among refugees in Athens.

Authors:  Anastasios Roussos; Constantin Goritsas; Thomas Pappas; Maria Spanaki; Panagiota Papadaki; Angeliki Ferti
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

2.  Steatosis and steatohepatitis in postmortem material from Northwestern Greece.

Authors:  Christos-D Zois; Gerasimos-H Baltayiannis; Anna Bekiari; Anna Goussia; Peter Karayiannis; Michalis Doukas; Demetrios Demopoulos; Antigoni Mitsellou; Theodoros Vougiouklakis; Vasiliki Mitsi; Epameinondas-V Tsianos
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

3.  Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection.

Authors:  G N Dalekos; K Achenbach; D Christodoulou; G K Liapi; E K Zervou; D A Sideris; E V Tsianos
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

4.  Hepatitis B and C markers among alcoholics in Israel: high incidence of HCV infection.

Authors:  I Srugo; E Shinar; S Bar-Shany; L Amos
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

5.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.

Authors:  Paraskevi Mina; Sarah P Georgiadou; Christos Rizos; George N Dalekos; Eirini I Rigopoulou
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

6.  Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study.

Authors:  M Koulentaki; M Ergazaki; J Moschandrea; S Spanoudakis; N Tzagarakis; P E Drandakis; D A Spandidos; E A Kouroumalis
Journal:  BMC Public Health       Date:  2001-12-21       Impact factor: 3.295

7.  The changing epidemiology of hepatitis B in Greece.

Authors:  Eirini I Rigopoulou; Nikolaos K Gatselis; Konstantinos Galanis; Vasiliki Lygoura; Stella Gabeta; Kalliopi Zachou; George N Dalekos
Journal:  Ann Gastroenterol       Date:  2021-02-26

8.  New data concerning the epidemiology of Hepatitis B virus infection in Greece.

Authors:  Konstantinos D Pantazis; Ioannis S Elefsiniotis; Hero Brokalaki
Journal:  Gastroenterol Res Pract       Date:  2008       Impact factor: 2.260

Review 9.  Epidemiology of hepatitis C in Greece.

Authors:  Christos Triantos; Christos Konstantakis; Paraskeui Tselekouni; Maria Kalafateli; Ioanna Aggeletopoulou; Spilios Manolakopoulos
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.